Aging cohort of perinatally human immunodeficiency virus-infected children in New York City
- 1 May 2001
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 20 (9) , 511-517
- https://doi.org/10.1097/00006454-200105000-00008
Abstract
Background. New York City (NYC) pediatricians are now caring for fewer HIV-infected infants and more school age children and adolescents than earlier in the epidemic. Methods. Clinical, laboratory and demographic data were abstracted from medical records at 10 NYC centers participating in the CDC Pediatric Spectrum of HIV Disease project. Pediatric AIDS cases and HIV-related deaths reported to the NYC Department of Health were examined. Results. Median age of HIV-infected children in care increased from 3 years in 1989 to 1991 to 6 years in 1995 to 1998. The number of HIV-infected women giving birth in NYC declined 50% from 1990 to 1997 (1630 to 831); increasing numbers were identified prenatally (14% in 1989; 78% after 1995); and most received prenatal zidovudine prophylaxis (73% in 1997). Estimated perinatal transmission decreased to 10% by 1997. Improved identification of seropositive status in infants was associated with an increased proportion of infected infants receiving Pneumocystis carinii pneumonia (PCP) prophylaxis, 84% in 1997. AIDS free survival was longer for children born 1995 to 1998 than for those born before 1995, P = 0.004. In 1998 among children with advanced immunosuppression (CDC category 3), 66% were prescribed 3 or more antiretroviral medicines and 88% received PCP prophylaxis. Citywide AIDS cases and HIV-related deaths fell precipitously beginning in 1996. Conclusions. Based on the observations of this study, the cohort of NYC HIV-infected children in care is aging, associated with a decline in new HIV infections, high rates of PCP prophylaxis and increased time to AIDS. Falling HIV-related deaths citywide support these observations.Keywords
This publication has 19 references indexed in Scilit:
- Lack of Definitive Severe Mitochondrial Signs and Symptoms among Deceased HIV‐Uninfected and HIV‐Indeterminate Children ≤ 5 Years of Age, Pediatric Spectrum of HIV Disease Project (PSD), USAAnnals of the New York Academy of Sciences, 2000
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Impact of zidovudine use on risk and risk factors for perinatal transmission of HIVAIDS, 1998
- Effect of maternal CD4 + cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infectionThe Journal of Pediatrics, 1997
- Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected ChildrenNew England Journal of Medicine, 1997
- Combination Treatment with Zidovudine, Didanosine, and Nevirapine in Infants with Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1997
- After AIDS Clinical Trial 076: The Changing Pattern of Zidovudine Use during Pregnancy, and the Subsequent Reduction in the Vertical Transmission of Human Immunodeficiency Virus in a Cohort of Infected Women and Their InfantsThe Journal of Infectious Diseases, 1996
- Pregnancy rates among women infected with human immunodeficiency virusObstetrics & Gynecology, 1996
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Relation of the Course of HIV Infection in Children to the Severity of the Disease in Their Mothers at DeliveryNew England Journal of Medicine, 1994